Clinical Trial Update: A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients [Phase 3]

View source ↗

Summary

Phase III randomized trial investigating treatment strategies for nasopharyngeal carcinoma in the neoadjuvant setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Nasopharyngeal Carcinoma, Neoadjuvant Chemotherapy | Phase 3 | Status: UNKNOWN